Inceptionr LLC Xencor Inc Transaction History

Inceptionr LLC

$414 Billion
Q3 2025

A detailed history of Inceptionr LLC transactions in Xencor Inc stock. As of the latest transaction made, Inceptionr LLC holds 13,007 shares of XNCR stock, worth $194,194. This represents 0.04% of its overall portfolio holdings.

Number of Shares

13,007

Holding current value

$194,194

% of portfolio

0.04%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2025 Nov 13, 2025	BUY	$7.0 - $11.73 $91,049 - $152,572	13,007 New	13,007 $153 Million
Q1 2025 May 12, 2025	BUY	$10.64 - $24.13 $118,125 - $267,891	11,102 New	11,102 $118 Million

Others Institutions Holding XNCR

# of Institutions

216

Shares Held

81.9M

Call Options Held

Put Options Held

Black Rock Inc. New York, NY

11.1M
Shares

$166 Million
0.0% of portfolio
Primecap Management CO Pasadena, CA

10.7M
Shares

$159 Million
0.1% of portfolio
Vanguard Group Inc Valley Forge, PA

7.1M
Shares

$106 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

6.22M
Shares

$92.9 Million
0.98% of portfolio
Eco R1 Capital, LLC San Francisco, CA

6.14M
Shares

$91.7 Million
5.41% of portfolio

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $891M
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inceptionr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inceptionr LLC with notifications on news.

Account